Healthtech Startups
16,920 companies tagged Healthtech, with their investors and founders.
eMurmur is a software platform that enables remote and in-person auscultation (listening to body sounds) using digital stethoscopes, allowing healthcare providers to screen, monitor, diagnose, and consult on heart, lung, and bowel health. The platform operates via a web portal and mobile app, supporting live streaming, specialist consultation, and integration with electronic health records and telemedicine systems.
2 investors
ENA Respiratory develops and brings respiratory treatments to market across the US and other regions. The company operates at the intersection of pharmaceutical product development and clinical innovation, with deep expertise in bringing early-stage respiratory therapies through development and regulatory approval.
2 investors
EnableComp provides revenue cycle management solutions to hospitals, using adaptive intelligence to accelerate claims recovery and improve financial performance. The company specializes in resolving complex revenue cycle issues that traditional approaches fail to address.
2 investors
ENB Therapeutics develops small molecules targeting the endothelin B receptor (ETBR) in the tumor microenvironment to treat drug-resistant cancers by restoring immune cell infiltration and promoting tertiary lymphoid organ formation. Its preclinical therapies target cancers including melanoma, glioblastoma, squamous cell carcinoma, bladder cancer, and ovarian cancer.
2 investors
Encapsulate builds automated tumor-on-a-chip systems that test microtumors derived from patient biopsies against treatment regimens to predict how individual cancer patients will respond, delivering personalized insights in under seven days. It serves oncologists, pharmaceutical companies, and cancer researchers, drawing on a patient biobank for drug testing, patient stratification, and mechanism studies.
2 investors
2 investors
Endless Health provides an all-in-one platform and strategic support for wellness professionals to launch and scale preventive health practices, combining precision lab testing, practice management software, and personalized coaching infrastructure.
2 investors
Endogene is a biotech company focused on uterine biology, developing tools to improve the understanding, diagnosis, and treatment of uterine diseases.
2 investors
Endor Health is building a modern, automated platform to help people living with diabetes access care and supplies. The company aims to simplify the fragmented experience of managing diabetes for the diabetes community.
2 investors
Abbott's cardiovascular division provides cardiac and vascular medical devices and technologies, including electrophysiology products for treating conditions such as AFib and remote hemodynamic monitoring for heart failure. It serves healthcare professionals with product, reimbursement, and training resources, as well as patients and caregivers.
2 investors
Endospan develops endovascular stent graft systems, including the NEXUS Multi-Branch Aortic Arch Stent Graft System, for repairing aortic aneurysms and dissections in patients whose anatomy is unsuitable for traditional EVAR/TEVAR therapy. The company operates in the medical device sector, serving the endovascular aortic repair market.
2 investors
Endostart develops and manufactures medical devices for gastrointestinal endoscopy, aimed at healthcare sector professionals. Founded in 2018, the company operates in the medical device industry.
2 investors
Endo Tools Therapeutics develops endoscopic devices to enable minimally invasive therapeutic surgical procedures in gastroenterology. The company serves physicians and patients requiring complex gastrointestinal interventions.
2 investors
Company whose formation and launch the LifeSci team supported.
2 investors
Enlitic provides artificial intelligence solutions for healthcare systems to improve medical imaging data quality and unlock new revenue opportunities. The company's intelligent data framework enhances data quality, orchestrates workflows, and enables better comprehension of imaging archives.
2 investors
Enrichly is a digital platform for pediatric behavioral health that combines gamified engagement with evidence-based interventions to strengthen self-esteem and emotional wellness in children and adolescents. It serves clinicians, therapists, counselors, parents, and schools with a closed-loop system that tracks progress and delivers data-driven insights.
2 investors
Ensho is a biopharmaceutical company developing NSHO-101, an oral, selective small molecule Ξ±4Ξ²7 inhibitor intended as a once-daily treatment for patients with inflammatory bowel disease (IBD). The drug candidate, acquired from EA Pharma, is designed as an oral alternative to biologic therapies and as an anchor for oral combination therapy, and is currently in Phase 1 clinical development.
2 investors
Enspire DBS is conducting a clinical trial evaluating Deep Brain Stimulation combined with physical therapy (DBS + Rehab) to assess safety and whether it can improve arm function in stroke patients with lasting impairment. The company develops an investigational neurostimulation device for post-stroke rehabilitation.
2 investors
enstem develops industry-specific services for non-desk workers that use smartwatches and vital-sensing devices to monitor health and safety. Its offerings target the logistics/transportation industry and on-site field workers in Japan.
2 investors
Entelexo develops engineered exosome therapeutics for autoimmune diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis. The company uses a proprietary platform to design exosomes that communicate with multiple diseased cell types simultaneously, replacing traditional single-target treatments.
2 investors
ENTER provides healthcare payment solutions that help medical providers accelerate revenue collection and increase earnings through revenue cycle management and patient collections services.
2 investors
Enterprise Therapeutics is a drug discovery company developing therapies for respiratory diseases such as cystic fibrosis, asthma, and COPD. Its research targets the underlying mechanisms of mucus congestion in the lungs to reduce lung infections and improve patient quality of life.
2 investors
Enthea provides access to mental health treatment, including psychedelic-assisted therapy, positioned as a safe and affordable benefit for employers and healthcare consumers. The company serves corporate wellness programs, insurance plans, and health systems seeking to expand mental health treatment options.
2 investors
Envirotainer provides temperature-controlled solutions for the pharmaceutical supply chain, serving healthcare providers and pharmaceutical distributors. The company offers tailored solutions across different stages of the pharmaceutical lifecycle.
2 investors